Previous close | 0.0500 |
Open | 0.0500 |
Bid | 0.0000 |
Ask | 2.7500 |
Strike | 37.00 |
Expiry date | 2024-05-17 |
Day's range | 0.0500 - 0.0500 |
Contract range | N/A |
Volume | |
Open interest | 2 |
PTC Therapeutics, Inc. ( NASDAQ:PTCT ) shareholders will have a reason to smile today, with the analysts making...
PTC Therapeutics (PTCT) gains 21% on May 20 after the EC decided against adopting the negative CHMP opinion of January 2024 on the annual renewal of the conditional approval of Translarna.
PTC stock opened at a nine-month high Monday after the EC decided against pulling its drug, Translarna, from the market.